UBA1 Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia
Open Access
- 27 September 2022
- journal article
- letter
- Published by Wiley in HemaSphere
- Vol. 6 (10) , e775
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1Blood Advances, 2021
- Copper DeficiencyNew England Journal of Medicine, 2021
- Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune diseaseLeukemia, 2021
- VEXAS SyndromeBlood, 2021
- Novel somatic mutations in UBA1 as a cause of VEXAS syndromeBlood, 2021
- Vacuolization of hematopoietic precursors: an enigma with multiple etiologiesBlood, 2021
- Therapeutic options in VEXAS syndrome: insights from a retrospective seriesBlood, 2021
- Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory DiseaseNew England Journal of Medicine, 2020
- Recurrent Sweet's syndrome in a patient with multiple myelomaClinical Case Reports, 2018
- Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex biasNature Genetics, 2016